Early Phase 1 Lymphoma Trial, Recruiting NCT05800405 Sponsor: City of Hope Medical Center Condition: Lymphoma
Back to Lymphoma

Early Phase 1 Lymphoma Trial, Recruiting

NCT05800405
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have given their written agreement to take part (or whose legal representative has done so on their behalf)
  • Adults aged 18 years or older
  • People whose general health and ability to carry out daily activities meets a minimum level, as measured by standard scoring tools used in cancer care (confirm with trial site)
  • People who have been diagnosed with large B-cell lymphoma confirmed through laboratory testing of tissue
  • People whose lymphoma has come back or has stopped responding to previous treatment
  • People who are scheduled to receive a commercial CAR T-cell treatment (a type of immune cell therapy) within 3 months of joining the trial
  • People with 6 or fewer areas of active disease that can be targeted with a specific radiation planning approach (confirm with trial site)
  • People who have at least one tumour area large enough to be measured on a CT or MRI scan (at least 1.5 cm)
  • People who have mostly recovered from side effects of previous cancer treatments (minor side effects at a low level are acceptable; hair loss is an exception)
  • Women who could become pregnant must have a negative pregnancy test within 30 days before starting the trial treatment

Who may not be able to join:

  • People who have previously received a therapy that targets the CD19 protein
  • People who have had radiation therapy within the 21 days before starting the trial treatment
  • People who have lymphoma affecting the central nervous system (brain or spinal cord)
  • People with a history of serious allergic reactions to medications similar to the one used in this trial
  • People who currently have active diarrhoea
  • People with a significant ongoing illness that is not well controlled
  • People who currently have an active infection being treated with antibiotics
  • People who have another active cancer in addition to large B-cell lymphoma
  • People who are pregnant
  • People whose overall situation, in the trial doctor's judgement, would make participation unsafe
  • People who, in the trial doctor's opinion, may not be able to follow all of the trial's required procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
20 July 2023
Est. completion
4 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of participants completing planned radiation therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov